---
uid: 20260215154700
title: Metabolomics (174 Markers) Enables Precise T2D Pathogenesis Diagnosis and Rx
authors: Tsoukalas (~2018)
year: 2018
tags: [lit, dt-clinic, diabetes-type2, metabolomics, gc-ms, ir-biomarker, phd-biomarker, adipic-acid, vitD, insulin-resistance, hidden-hunger, microbiome, stress, beta-cell, reversal, diaDEM]
aliases: [Metabolomics_T2D]
status: atomic-strong
parent-moc: [[55-MOCs/MOC_DT_Diabetes_T2D]] | [[22-Dashboards/PhD_IR_MOC]]
chain-next: [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]]
confidence: high
cited_refs: [[66-Literature/Diabetes_Type2_Pathogenesis_Tsoukalas_20260215_003]]
---

# Metabolomics_T2D_Diagnosis_20260215_023

**Strong Claim**: Metabolomics profiles 174 markers to diagnose T2D drivers (IR/adipic/VitD gaps) for personalized reversal Rx.

**Evidence** (Tsoukalas): GC-MS precision > standard labs; PhD adipic as key IR proxy.

**Implication**: Baseline + post-Rx tracking; chain to protocols.

[[33-Atomic/T2D_Epidemic_IR_Central_20260215_017]] â†’ [[33-Atomic/Adipic_T2D_IR_Biomarker_20260215_026]].